In T2DM, elevated levels of proinflammatory cytokines, such as IL-6 and IFN-γ, activate the JAK2/STAT3 pathway, leading to the upregulation of SOCS3, which inhibits the activation IRS-1 [37,38]. This evidence concerns the gene IL6 and type 2 diabetes mellitus.